EHA 2026: Long-Term Outcomes with Zanubrutinib in First-Line CLL
/ Wojciech Jurczak
Nine-Year Outcomes with Nivolumab in Melanoma
/ Paolo Ascierto
WISDOM: Risk-Based Breast Cancer Screening
/ Martin Eklund
Cost-Effectiveness of Breast Cancer Screening in Europe
/ Zacharoula Sidiropoulou
Chemotherapy Use After the RxPONDER Trial
/ Jason Jincong Freeman
Maternal RSV Vaccination Strongly Reduces Infant Hospitalization Risk
/ Helena Smith-Hall
EAN 2026: Dropped Head Syndrome - A Diagnostic Challenge
/ Nils Erik Gilhus











